People living with motor neurone disease (MND) can now create bespoke digital artwork through an artificial intelligence (AI) art platform which harnesses the power of eye-gaze...
Professor Dame Pamela Shaw joins to help advance development of its ALS/MND drug candidate SAM001
Motor Neurone Disease research has long been underfunded, but the pathway towards better treatments – and potentially a cure – seems within reach. Over 2000 people...
Disabled people among hardest hit by cost of living crisis, research reveals
How husband's passing inspired a movement in neurological health.
Researchers have shown “top-line” results from the phase 2b trial of low dose Interleukin-2 (ld IL2) in MND patients. The MIROCALS (Modifying Immune Response and Outcomes...
Findings prompt MND Association to launch campaign calling on government to undertake a full review of carers’ assessments
Motor neurone disease (MND) affects up to 5,000 adults in the UK at any one time
Pioneering molecular biologist Professor Justin Yerbury on his MND diagnosis and international recognition
New research reveals the potential of the drug terazosin in supporting those with motor neuron disease
